News

GMC: 'Unproblematic' introduction of civil proof standard

03-Jul-08

The GMC says that the introduction of the civil standard of proof into its fitness-to-practise cases has been ‘quite unproblematic’.

One month after the controversial new standard came into force, no cases have caused any difficulty, the Council's director of standards and fitness to practise Paul Philip said.

‘I still anticipate that there will be a legal challenge,' he added. ‘We would welcome the opportunity for any directive from the High Court to say what should and shouldn't happen.'

The defence societies are expecting the numbers of doctors suspended or erased to increase with the ‘much lower standard of proof'.

The GMC is keeping the new standard under review and is expected to report by the end of the year.

prisca.middlemiss@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Journals club - HPV vaccine

Curriculum statement 5. Healthy people: promoting health and preventing disease. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs

 

Job of the Week